Victoria Biomedical Research Institute
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tina, Lucas O
NOVATION-1, NCT04669015: Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Recruiting
3
914
Canada, RoW
Novaferon, Standard of Care, Placebo
Genova Inc.
Covid19
08/22
08/22
NCT05974267: Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)

Completed
2
192
RoW
M5717 60 mg, Pyronaridine, Pyronaridine tetraphosphate, Atovaquone-Proguanil, M5717 200 mg, M5717 660mg
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Malaria Infection
12/24
12/24

Download Options